COVID-19对院外心脏骤停恢复自主循环患者死亡率的影响:一项回顾性队列研究
本研究利用美国Collaborative Network(TriNetX)2020年1月1日至2023年12月31日的记录,纳入25,271例住院的院外心脏骤停患者,比较COVID-19阳性与阴性组的死亡率。每组各纳入2,776例。主要终点为14天和90天死亡率:COVID-19组14天死亡率较低(HR 0.82,95%CI 0.76-0.88),但90天死亡率较高(HR 1.16,95%CI 1.09-1.24)。亚组分析显示,65岁以下及65岁及以上COVID-19患者死亡率均较高,男性COVID-19患者死亡风险升高,Alpha和Delta变异流行期COVID-19患者死亡率高于非COVID-19患者。结论认为COVID-19与OHCA患者较高的死亡风险相关。
要点
- 在住院的OHCA恢复自主循环患者中,COVID-19阳性组14天死亡率低于阴性组(HR 0.82,95%CI 0.76-0.88)。
- 同一人群中,COVID-19阳性组90天死亡率高于阴性组(HR 1.16,95%CI 1.09-1.24)。
- 亚组分析显示,65岁以下COVID-19患者死亡率较高,65岁及以上人群该趋势持续存在。
- 男性COVID-19患者死亡风险升高;Alpha和Delta变异流行期COVID-19患者死亡率高于非COVID-19患者。
适用人群与场景
- 住院的院外心脏骤停(OHCA)患者,数据来自美国Collaborative Network(TriNetX),记录时间2020年1月1日至2023年12月31日。
- 研究人群分为COVID-19阳性组与COVID-19阴性组,每组各2,776例。
研究设计与关键结果
- 研究类型:回顾性队列研究;数据来源:美国Collaborative Network(TriNetX);总招募25,271例住院OHCA患者,最终每组纳入2,776例。
- 主要终点:COVID-19阳性组14天死亡率低于阴性组(HR 0.82,95%CI 0.76-0.88);90天死亡率高于阴性组(HR 1.16,95%CI 1.09-1.24)。
- 亚组分析:65岁以下COVID-19患者死亡率较高,65岁及以上人群该趋势持续存在;男性COVID-19患者死亡风险升高;Alpha和Delta变异流行期COVID-19患者死亡率高于非COVID-19患者。
- 结论:COVID-19与OHCA患者较高的死亡风险相关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于住院的OHCA恢复自主循环患者,合并COVID-19可能提示需关注90天死亡风险升高,作者结论认为COVID-19与较高的死亡风险相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aims to compare the mortality rates of OHCA patients with and without COVID-19 infection across different follow-up periods and explores the factors may play a significant role in determining OHCA outcomes.
METHODS: This study utilized data from the US Collaborative Network in TriNetX. A total of 25,271 hospitalized OHCA patients were recruited from records spanning from January 1, 2020, to December 31, 2023. Study population divided into two groups, COVID-19 positive and COVID-19 negative groups. The mortality risk of the two groups was observed based on different follow-up periods. Subgroup analyses on sex, age, antivirals use, COVID-19 virus variant epidemic period were also conducted.
RESULTS: Our study included 2,776 patients in each group (COVID vs. non-COVID). The primary outcome was mortality at 14-day and 90-day follow-ups. COVID-19 patients had a lower 14-day mortality (HR 0.82, 95% CI: 0.76-0.88) but higher 90-day mortality (HR 1.16, 95% CI: 1.09-1.24) compared to non-COVID-19 patients. Secondary outcomes included higher mortality in COVID-19 patients under 65, and this trend persisted in those aged 65 and over. Male COVID-19 patients had elevated mortality risk. The Alpha and Delta variant period showed a higher mortality rate for COVID-19 patients than non-COVID-19 patients.
CONCLUSION: COVID-19 was associated with a higher risk of mortality in OHCA patients.
参考来源
- Shih NC, Yeh HW, Yang SF, et al. Impact of COVID-19 on mortality in out-of-hospital cardiac arrest patients with return of spontaneous circulation: a retrospective cohort study. Scand J Trauma Resusc Emerg Med. 2025. PMID: 40312395. doi:10.1186/s13049-025-01395-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。